carbachol has been researched along with Cancer of Salivary Gland in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cells of the HSG cell line derived from a human submandibular gland adenocarcinoma and those of the A-431 human epidermoid carcinoma cell line were loaded with a fluorescent pH indicator, BCECF/AM, and the change in the intracellular pH of adherent cells and suspended ones were measured following stimulation with various concentrations (10(-7) M to 10(-2) M) of neurotransmitters (carbachol, noradrenaline, and isoproterenol)." | 3.70 | Alkalization produced by high-dose carbachol in HSG cell line is independent of Ca2+. ( Atsumi, T; Iwakura, I; Ueha, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, T | 1 |
| Iwakura, I | 1 |
| Ueha, T | 1 |
1 other study available for carbachol and Cancer of Salivary Gland
| Article | Year |
|---|---|
Alkalization produced by high-dose carbachol in HSG cell line is independent of Ca2+.
Topics: Acid-Base Equilibrium; Adenocarcinoma; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Calcium | 1998 |